{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"3.000","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"526,579,084","primaryexch":"香港交易所","ric":"2216.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BLGZLK2","am":"5.48","iv":"","ew_strike":"","as":"2.830","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"2.800","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-28 00:06:03.0","lo52":"0.460","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"徐宏","underlying_ric":"2216.HK","hi52":"3.720","issuer_name":"堃博醫療控股有限公司 - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"2.770","mkt_cap":"1.47","f_aum_hkd":null,"ew_sub_per_to":"","ls":"2.800","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 其他醫療保健","ew_desc":null,"inception_date":"","nc":"-0.080","aum":"","issued_shares_class_B":null,"vo":"1.92","secondary_listing_flag":false,"listing_date":"2021年9月24日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"堃博醫療控股有限公司 - B","nm_s":"堃博醫療－Ｂ","sym":"2216","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"堃博醫療控股有限公司是一家提供創新肺部疾病解決方案的投資控股公司。該公司的業務包括提供診斷解決方案、肺癌治療解決方案、慢性阻塞性肺病解決方案和導航平台。診斷解決方案的產品包括FleXNeedle，ATV鞘管和ATV球囊等。肺癌治療解決方案產品包括針對肺癌的InterVapor和H-Marker等。慢性阻塞性肺病解決方案產品包括針對慢性阻塞性肺病的InterVapor和標靶肺去神經消融系統。導航平台產品包括Lungpoint，Lungpro，和新一代導航系統等。","op":"3.000","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"醫療設備及用品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港灣仔<br/>皇后大道東248號<br/>大新金融中心<br/>40樓","pc":"-2.78","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"USD","hdr":false,"launch_date":"","hc":"2.880","isin":"KYG1609T1022","moneyness":""}},"qid":"1759074444668"}
